Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice
Authors
Keywords
CTGVT, Oncolytic adenovirus, ZD55-IL-24, Pancreatic cancer, Immune-competent
Journal
MOLECULAR BIOLOGY REPORTS
Volume 40, Issue 9, Pages 5397-5405
Publisher
Springer Nature
Online
2013-05-10
DOI
10.1007/s11033-013-2638-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene
- (2012) Bin Xu et al. CANCER
- Gene and Viral Therapy for Glioblastoma
- (2012) Ahmed Mohyeldin et al. CANCER JOURNAL
- Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a Trend in Both Cancer Gene Therapy and Cancer Virotherapy
- (2012) Xin -Yuan Liu et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Fighting fire with fire: rewiring tumor cells for oncolytic virotherapy
- (2012) Douglas J Mahoney et al. Future Oncology
- Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
- (2012) Sandeep S. Patil et al. Journal of Translational Medicine
- T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer
- (2012) Danian Tong et al. MOLECULAR BIOLOGY REPORTS
- Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy
- (2011) Guan Jiang et al. ACTA ONCOLOGICA
- Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
- (2011) Ryuichi Kanai et al. JNCI-Journal of the National Cancer Institute
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
- (2011) Alan Melcher et al. MOLECULAR THERAPY
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Seek and destroy: oncolytic virus shows promise in phase I trial
- (2011) Christoph A. Schmitt Nature Reviews Clinical Oncology
- An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer
- (2010) Suyang Zhong et al. ACTA ONCOLOGICA
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity
- (2010) Rupesh Dash et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Antitumor activity of an adenovirus harboring human IL-24 in colon cancer
- (2010) Shujian Chang et al. MOLECULAR BIOLOGY REPORTS
- The development of MDA-7/IL-24 as a cancer therapeutic
- (2010) Paul Dent et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo
- (2009) C Yang et al. CANCER GENE THERAPY
- Mechanism of In vitro Pancreatic Cancer Cell Growth Inhibition by Melanoma Differentiation-Associated Gene-7/Interleukin-24 and Perillyl Alcohol
- (2008) I. V. Lebedeva et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started